Literature DB >> 12862403

In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa.

Edmund Hofer1, Andreas Neher, Andreas R Gunkel, Markus Nagl.   

Abstract

BACKGROUND: The aim of this study was to investigate the in vitro effects of N-chlorotaurine (NCT), a new endogenous antimicrobial agent, on the nasal ciliary beat frequency (CBF) in nasal mucosa samples of 10 adult patients who underwent conchotomy.
METHODS: CBF was measured by a photometric technique, combining a light microscope, a photometer, a photograph multiplier, and a computed analyzing unit.
RESULTS: CBF decreased approximately 10% after 20 minutes of incubation in aqueous 1% NCT solution compared with 3% in 0.9% saline, and 0.1 and 0.01% NCT had no effect. However, a solution of 7% cocaine, which is used routinely for shrinking the nasal mucosa before rhinoscopy lowered the CBF to 50% after the same incubation time.
CONCLUSION: These results confirm the very low toxic potential of NCT, and they are fundamental for clinical investigations regarding its topical application in the nasal and paranasal sinuses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12862403

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  5 in total

1.  [Therapy-resistant otitis externa with additional tympanic membrane perforation: local therapy using N-chlorotaurine and dexamethasone].

Authors:  M Lumassegger; M Nagl; C Pototschnig; A Neher
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

2.  Inactivation of Adenovirus in Water by Natural and Synthetic Compounds.

Authors:  Lucas Ariel Totaro Garcia; Laurita Boff; Célia Regina Monte Barardi; Markus Nagl
Journal:  Food Environ Virol       Date:  2019-02-04       Impact factor: 2.778

Review 3.  N-Chlorotaurine, a Promising Future Candidate for Topical Therapy of Fungal Infections.

Authors:  Markus Nagl; Roland Arnitz; Michaela Lackner
Journal:  Mycopathologia       Date:  2017-07-12       Impact factor: 2.574

4.  Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.

Authors:  Roland Arnitz; Markus Stein; Petra Bauer; Barbara Lanthaler; Herbert Jamnig; Sabine Scholl-Bürgi; Katharina Stempfl-Al-Jazrawi; Hanno Ulmer; Bernhard Baumgartner; Sabine Embacher; Simon Geisler; Johanna M Gostner; Bernhard Müllinger; Beate Kälz; Markus Nagl
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

5.  Tolerability of inhaled N-chlorotaurine in the pig model.

Authors:  Ralf Geiger; Benedikt Treml; Anna Pinna; Linn Barnickel; Harald Prossliner; Hannes Reinstadler; Michael Pilch; Maria Hauer; Christoph Walther; Hans-Jörg Steiner; Thomas Giese; Andreas Wemhöner; Sabine Scholl-Bürgi; Waldemar Gottardi; Roland Arnitz; Consolato Sergi; Markus Nagl; Alexander Löckinger
Journal:  BMC Pulm Med       Date:  2009-07-14       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.